Quantinno Capital Management LP lifted its stake in Amdocs Limited (NASDAQ:DOX - Free Report) by 10.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 88,795 shares of the technology company's stock after acquiring an additional 8,581 shares during the quarter. Quantinno Capital Management LP owned approximately 0.08% of Amdocs worth $7,768,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also bought and sold shares of the company. Private Trust Co. NA increased its stake in shares of Amdocs by 62.9% during the 3rd quarter. Private Trust Co. NA now owns 303 shares of the technology company's stock worth $27,000 after purchasing an additional 117 shares during the last quarter. Brooklyn Investment Group acquired a new position in Amdocs during the third quarter worth approximately $28,000. Catalyst Capital Advisors LLC acquired a new position in Amdocs during the third quarter worth approximately $55,000. GAMMA Investing LLC raised its stake in Amdocs by 115.1% in the third quarter. GAMMA Investing LLC now owns 800 shares of the technology company's stock valued at $70,000 after buying an additional 428 shares during the period. Finally, American National Bank acquired a new stake in shares of Amdocs in the second quarter valued at approximately $76,000. Institutional investors own 92.02% of the company's stock.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on DOX shares. Oppenheimer increased their price target on Amdocs from $98.00 to $105.00 and gave the company an "outperform" rating in a research note on Wednesday, November 13th. Stifel Nicolaus began coverage on shares of Amdocs in a research report on Wednesday, October 2nd. They issued a "buy" rating and a $100.00 price objective on the stock. Barclays cut their target price on shares of Amdocs from $113.00 to $111.00 and set an "overweight" rating for the company in a research note on Thursday, November 14th. Finally, StockNews.com lowered shares of Amdocs from a "strong-buy" rating to a "buy" rating in a research note on Thursday, November 14th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $101.20.
Check Out Our Latest Stock Analysis on Amdocs
Amdocs Stock Performance
Amdocs stock traded down $0.41 during midday trading on Friday, hitting $86.64. The company's stock had a trading volume of 779,784 shares, compared to its average volume of 678,839. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.20 and a quick ratio of 1.24. The company has a market cap of $10.18 billion, a price-to-earnings ratio of 20.43, a PEG ratio of 1.46 and a beta of 0.72. Amdocs Limited has a 1-year low of $74.41 and a 1-year high of $94.04. The company has a 50-day moving average price of $88.12 and a two-hundred day moving average price of $84.25.
Amdocs Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be given a $0.479 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.21%. Amdocs's payout ratio is 45.28%.
Amdocs Profile
(
Free Report)
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Further Reading
Before you consider Amdocs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amdocs wasn't on the list.
While Amdocs currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
